
Original ArticlemicroRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer
Keywords: Pancreatic cancer; microRNA; Multi drug resistance; Novel therapeutics; Bx-GEM; gemcitabine resistant BxPC3 subclone; CAM; chorioallantoic membrane; miR; micro-RNA; PDA; pancreatic ductal adenocarcinoma; RRM1; ribonucleotide reductase sub-unit M1; 3â² UT